Literature DB >> 17323001

Molecular mechanism of iron metabolism and overload in chronic hepatitis C.

Masahiko Kaito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17323001     DOI： 10.1007/s00535-006-1983-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  35 in total

1.  Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection.

Authors:  H Huang; H Fujii; A Sankila; B M Mahler-Araujo; M Matsuda; G Cathomas; H Ohgaki
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  TREATMENT OF CIRRHOSIS OF THE LIVER BY A NUTRITIOUS DIET AND SUPPLEMENTS RICH IN VITAMIN B COMPLEX.

Authors:  A J Patek; J Post
Journal:  J Clin Invest       Date:  1941-09       Impact factor: 14.808

3.  Measurements of iron status in patients with chronic hepatitis.

Authors:  A M Di Bisceglie; C A Axiotis; J H Hoofnagle; B R Bacon
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

4.  Dietary iron restriction improves aminotransferase levels in chronic hepatitis C patients.

Authors:  Motoh Iwasa; Masahiko Kaito; Jiro Ikoma; Yoshinao Kobayashi; Yuji Tanaka; Kunihiro Higuchi; Keisuke Takeuchi; Kazuko Iwata; Shozo Watanabe; Yukihiko Adachi
Journal:  Hepatogastroenterology       Date:  2002 Mar-Apr

Review 5.  Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation.

Authors:  Tomas Ganz
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

6.  Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C.

Authors:  Shinichiro Horiike; Shosuke Kawanishi; Masahiko Kaito; Ning Ma; Hideaki Tanaka; Naoki Fujita; Motoh Iwasa; Yoshinao Kobayashi; Yusuke Hiraku; Shinji Oikawa; Mariko Murata; Jinyan Wang; Reiji Semba; Shozo Watanabe; Yukihiko Adachi
Journal:  J Hepatol       Date:  2005-09       Impact factor: 25.083

7.  Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse.

Authors:  C D Vulpe; Y M Kuo; T L Murphy; L Cowley; C Askwith; N Libina; J Gitschier; G J Anderson
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

Review 8.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.

Authors:  Naoki Fujita; Ryosuke Sugimoto; Masaki Takeo; Naohito Urawa; Rumi Mifuji; Hideaki Tanaka; Yoshinao Kobayashi; Motoh Iwasa; Shozo Watanabe; Yukihiko Adachi; Masahiko Kaito
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

10.  Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C.

Authors:  H Hayashi; T Takikawa; N Nishimura; M Yano
Journal:  J Hepatol       Date:  1995-03       Impact factor: 25.083
View more
  7 in total

Review 1.  Crossing the Iron Gate: Why and How Transferrin Receptors Mediate Viral Entry.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2018-05-31       Impact factor: 11.848

2.  Entry Inhibitors of Hepatitis C Virus.

Authors:  Xi-Jing Qian; Zhong-Tian Qi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  The effect of iron depletion on chronic hepatitis C virus infection.

Authors:  Massimo Franchini; Giovanni Targher; Franco Capra; Martina Montagnana; Giuseppe Lippi
Journal:  Hepatol Int       Date:  2008-05-08       Impact factor: 6.047

4.  Efficacy and safety of addition of minor bloodletting (petit phlebotomy) in hepatitis C virus-infected patients receiving regular glycyrrhizin injections.

Authors:  Naoki Tanaka; Akira Horiuchi; Takahiro Yamaura; Michiharu Komatsu; Takahide Yokoyama; Shinji Okaniwa; Tadanobu Nagaya; Kaname Yoshizawa; Kendo Kiyosawa; Toshifumi Aoyama; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2009-04-08       Impact factor: 7.527

5.  Identification of transferrin receptor 1 as a hepatitis C virus entry factor.

Authors:  Danyelle N Martin; Susan L Uprichard
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

Review 6.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

Review 7.  Entry inhibitors: New advances in HCV treatment.

Authors:  Xi-Jing Qian; Yong-Zhe Zhu; Ping Zhao; Zhong-Tian Qi
Journal:  Emerg Microbes Infect       Date:  2016-01-06       Impact factor: 7.163
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.